Join the Precocious Puberty group to help and get support from people like you.
Precocious Puberty News
Some Genes Might Send Girls Into Puberty Earlier
TUESDAY, July 2, 2024 – A girl’s genetics can indirectly influence the age when she has her first period, by accelerating her weight gain in childhood, a new study finds. A number of other genes a...
U.S. Girls Are Beginning Periods Earlier
WEDNESDAY, May 29, 2024 – U.S. girls are getting their periods at younger ages, a new study has found. Girls born between 2000 and 2005 started their periods at an average age of 11.9 years – a...
Timing of Pubertal Development Tied to Adult Cardiometabolic Risk
WEDNESDAY, March 27, 2024 – Pubertal development and its timing may be an important pathway through which early-life exposures shape adulthood cardiometabolic health and disease, according to a...
Air Pollution Exposure Before Birth May Harm Reproductive Development: Study
WEDNESDAY, Nov. 15, 2023 – Air pollution could be harming the development of children, reaching into the womb to alter their healthy growth, a new study reports. Researchers say certain air...
Melatonin Use Skyrockets Among U.S. Kids, Study Finds
WEDNESDAY, Nov. 15, 2024 – Record numbers of children and tweens now take melatonin for sleep, potentially doing harm to their development, a new study warns. Nearly one in five school-aged kids are...
PFAS Chemicals Tied to Later Puberty in Girls
TUESDAY, Oct. 3, 2023 – Exposure to ubiquitous chemicals known as PFAS, or per- and polyfluoroalkyl substances, may delay puberty in girls, new research indicates. The study is the first to consider t...
FDA Approves Fensolvi (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty
BUFFALO GROVE, Ill., May 4, 2020 /PRNewswire/ – Tolmar Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application for Fensolvi...
Arbor Pharmaceuticals, LLC Announces FDA Approval for Triptodur (triptorelin)
Atlanta, GA and Lausanne, Switzerland – June 30, 2017 – Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, and Debiopharm International SA, part of Debiopharm Group™, a Swiss...